BioArctic ABBRCTF 84 Operating Margin % is 48.18% as of Mar. 2026, which is 72% above its 10-year median of 28.01. GuruFocus rates BRCTF with a GF Score™ of 84/100 and a GF Value™ of $49.29 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 945 Biotechnology companies, BioArctic AB ranks better than 94.6% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. BioArctic AB's Operating Income for the
three
months ended in Mar. 2026 was $22.6 Mil. BioArctic AB's Revenue for the
three
months ended in Mar. 2026 was $47.0 Mil. Therefore, BioArctic AB's Operating Margin % for the quarter that ended in Mar. 2026 was 48.18%.
The historical rank and industry rank for BioArctic AB's Operating Margin % or its related term are showing as below:
BRCTF'
s Operating Margin % Range Over the Past 10 Years
Min: -604.22 Med: 28.01 Max: 68.44
Current: 34.38
BRCTF's Operating Margin % is ranked better than 94.6% of 945
companies
in the Biotechnology industry
Industry Median: -86.89
vs BRCTF: 34.38
BioArctic AB's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
BioArctic AB's Operating Income for the
three
months ended in Mar. 2026 was $22.6 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was $41.9 Mil.
BioArctic AB (OTCPK:BRCTF) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
BioArctic AB Operating Margin % Related Terms
BioArctic AB Operating Margin % Historical Data
* Premium members only.
The historical data trend for BioArctic AB's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BRCTF vs VRTX, REGN, ALNY: Operating Margin % Comparison
For the Biotechnology subindustry, BioArctic AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioArctic AB Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioArctic AB's Operating Margin % distribution charts can be found below:
* The bar in red indicates where BioArctic AB's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
BioArctic AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioArctic AB (BRCTF) has a Operating Margin % of 48.18% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on BioArctic AB and its competitors. This is 72% above median its historical median of 28.01. According to the industry distribution chart, BioArctic AB ranks #51 out of 945 companies in the Biotechnology industry, placing it in the top 5.4%.
Is BioArctic AB's Operating Margin % too high?
BioArctic AB's current Operating Margin % of 48.18% is 72% above median its 10-year median of 28.01. Based on the distribution chart, BioArctic AB ranks #51 out of 945 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BioArctic AB has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioArctic AB's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BioArctic AB ranks #51 out of 945 companies for Operating Margin %. This places BioArctic AB in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on BioArctic AB and its competitors. BioArctic AB's current Operating Margin % is 48.18%, which is 72% above median its own 10-year median of 28.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioArctic AB stock overvalued right now?
Based on GuruFocus' analysis, BioArctic AB (BRCTF) is currently considered Modestly Undervalued. The stock's GF Value™ is $49.29, compared to a current price of $35.00 — trading 29% below its estimated fair value. The current Operating Margin % is 48.18%, which is 72% above median its 10-year median of 28.01. BioArctic AB's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For BioArctic AB (BRCTF), the current Operating Margin % is 48.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioArctic AB (BRCTF) Overvalued in 2026?
Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued.
The current stock price of $35.00 is trading 29% below its estimated GF Value™ of $49.29.
GuruFocus considers BioArctic AB to be Modestly Undervalued.
Key valuation signals for BRCTF:
Operating Margin %: 48.18% (72% above median its 10-year median of 28.01)
GF Value™: $49.29 vs. price of $35.00 (29% below fair value)
No single metric tells the full story. See the BRCTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
84GF Score
Get the complete analysis for BRCTF
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRCTF has been successfully added to your 
